Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_assertion type Assertion NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_head.
- NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_assertion description "[Considering that inclusions of lipofuscin-like substances are observed in retinal pigmentary cells of patients with Stargardt's disease on the one hand, and that the early symptoms of neuronal ceroid lipofuscinosis (CLN3) are suggestive of Stargardt's disease on the other hand (age of loss of visual acuity, appearance of the fundus), we decided to test allelism of Stargardt's disease with the infantile (CLN1) and juvenile forms of neuronal ceroid lipofuscinosis (CLN3), which map to chromosomes 1p32 and 16p12-p11 respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_provenance.
- NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_assertion evidence source_evidence_literature NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_provenance.
- NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_assertion SIO_000772 8014971 NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_provenance.
- NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_assertion wasDerivedFrom befree-20140225 NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_provenance.
- NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_assertion wasGeneratedBy ECO_0000203 NP811618.RAoFZtXpvv9EkGPntVsVNYumNfHROgS5pQkd2iaQt2E28130_provenance.